Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Description | TH1834 is a selective inhibitor of the Tip60 (KAT5) histone acetyltransferase (HAT). It effectively induces apoptosis and promotes DNA damage in breast cancer cells. Notably, TH1834 does not influence the activity of the MOF histone acetyltransferase, which is structurally related. Overall, TH1834 exhibits potent anticancer activity. |
In vitro | TH1834 treatment (0-500 μM; 1 hour; MCF7 cells) significantly reduces MCF7 cell viability and increases cytotoxicity. At 500 μM, TH1834 induces caspase 3 activation in MCF7 cells. TH1834 significantly inhibits Tip60 activity in vitro, leading to apoptosis and increased unrepaired DNA damage in breast cancer cells. [1] Cell Viability Assay[1] Cell Line: MCF7 cells Concentration: 0 μM, 0.5 μM, 5 μM, 50 μM, and 500 μM Incubation Time: 1 hour Result: Significantly reduced the viability of MCF7 cells. Cell Cytotoxicity Assay[1] Cell Line: MCF7 cells Concentration: 0 μM, 0.5 μM, 5 μM, 50 μM, and 500 μM Incubation Time: 1 hour Result: Highly significant increase in cytotoxicity at all concentrations used. Western Blot Analysis[1] Cell Line: MCF7 cells Concentration: 500 μM Incubation Time: 1 hour Result: Marked caspase 3 activation was observed in MCF7 cells in an independent assay. |
Alias | TH1834 |
Molecular Weight | 568.722 |
Formula | C33H40N6O3 |
Cas No. | 2108830-08-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.